Donaldson (DCI)
(Delayed Data from NYSE)
$77.55 USD
+0.57 (0.74%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $77.54 -0.01 (-0.01%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$77.55 USD
+0.57 (0.74%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $77.54 -0.01 (-0.01%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth B Momentum A VGM
Zacks News
Donaldson (DCI) Upgraded to Buy: Here's Why
by Zacks Equity Research
Donaldson (DCI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Donaldson (DCI) Q1 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
Donaldson's (DCI) fiscal first-quarter revenues increase year over year on account of impressive performance across its segments.
Donaldson (DCI) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Donaldson (DCI) delivered earnings and revenue surprises of 10.91% and 2.40%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?
Donaldson (DCI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Donaldson (DCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Donaldson (DCI) Acquires Solaris, Strengthens Market Presence
by Zacks Equity Research
Donaldson's (DCI) buyout of Solaris Biotechnology will enable it to enhance its product offerings and strengthen its presence across food and beverage, biopharma and other major life sciences markets.
Donaldson (DCI) Q4 Earnings Match Estimates, Revenues Beat
by Zacks Equity Research
Donaldson's (DCI) Q4 earnings increase year over year on improvement in sales and margins. It provides earnings and sales outlook for fiscal 2022.
Donaldson (DCI) Matches Q4 Earnings Estimates
by Zacks Equity Research
Donaldson (DCI) delivered earnings and revenue surprises of 0.00% and 0.50%, respectively, for the quarter ended July 2021. Do the numbers hold clues to what lies ahead for the stock?
Donaldson (DCI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Donaldson (DCI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks Industry Outlook Highlights: Donaldson Company, Tetra Tech, Energy Recovery and Heritage-Crystal Clean
by Zacks Equity Research
Zacks Industry Outlook Highlights: Donaldson Company, Tetra Tech, Energy Recovery and Heritage-Crystal Clean
4 Pollution Control Stocks With Solid Earnings Growth Potential
by Zacks Equity Research
Increased adoption of air pollution control equipment and services and environmental management programs are driving the pollution control industry. DCI, TTEK, ERII & HCCI are the likely winners from the industry.
Can Donaldson (DCI) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Donaldson (DCI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Parker-Hannifin (PH) to Post Q4 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Parker-Hannifin's (PH) fiscal Q4 earnings are likely to have gained from end-market strength, acquired assets and cost-control actions. Pandemic-led weakness across some end markets might have hurt.
Flowserve (FLS) to Post Q2 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Flowserve's (FLS) second-quarter earnings are likely to have gained from diversified business structure, solid backlog and focus on improving operational productivity.
Zebra (ZBRA) to Post Q2 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Zebra's (ZBRA) Q2 earnings are likely to have gained from solid demand for its products, acquired asset and focus on improving operational productivity. High costs & expenses might have hurt it.
Howmet Aerospace (HWM) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Howmet Aerospace (HWM) Q2 results to reflect gains from industrial gas turbine and commercial transportation demand. Commercial aerospace and supply-chain woes are likely to have been drags.
Emerson (EMR) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Emerson's fiscal Q3 (EMR) earnings are likely to have gained from strength in end markets, acquired asset and focus on improving operational productivity. High costs & expenses might have hurt it.
MRC Global (MRC) Q2 Earnings & Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
MRC Global's (MRC) second-quarter revenues increase 14% year over year on account of impressive performance across most of its segments.
Tetra Tech (TTEK) Q3 Earnings & Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
Tetra Tech's (TTEK) fiscal third-quarter revenues increase year over year on account of impressive performance across its segments.
Cimpress (CMPR) Q4 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Cimpress (CMPR) fourth-quarter fiscal 2021 revenues increase year over year, owing to solid performance across all of its segments.
A. O. Smith (AOS) Q2 Earnings & Revenues Surpass Estimates
by Zacks Equity Research
A. O. Smith's (AOS) second-quarter 2021 revenues increase 29.5% year over year on account of impressive performance across its segments.
Fortune Brands (FBHS) Q2 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Fortune Brands' (FBHS) second-quarter 2021 revenues increase 41% year over year on account of impressive performance across its segments.
Illinois Tool (ITW) to Post Q2 Earnings: Is a Beat in Store?
by Zacks Equity Research
Illinois Tool (ITW) Q2 results to reflect the impacts of healthy demand in the majority end markets served, gains from the enterprise strategy and supply-chain constraints in the automotive market.
Donaldson (DCI) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Donaldson (DCI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's Why it is Worth Investing in Tetra Tech (TTEK) Stock
by Zacks Equity Research
Tetra Tech (TTEK) stands to benefit from its diversified business structure, acquired assets, solid backlog level and shareholder-friendly policies.
Here's Why You Should Consider Investing in Donaldson (DCI)
by Zacks Equity Research
Donaldson (DCI) is likely to gain from strength in its businesses, strong portfolio of products, growth investments and shareholder-friendly policies.